Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.43B 1.25B 1.15B 1.06B 2.01B 138B 2.05B 13.78B 5.41B 67.32B 5.38B 5.26B 232B P/E 2026 *
28.3x
P/E 2027 * 15.3x
Enterprise Value 2.77B 2.42B 2.23B 2.05B 3.89B 267B 3.96B 26.67B 10.46B 130B 10.4B 10.17B 449B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.51x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day+2.80%
1 week+9.36%
Current month+5.35%
1 month+8.36%
3 months+71.53%
6 months+49.57%
Current year+52.33%
1 week 17.01
Extreme 17.01
19.13
1 month 17.01
Extreme 17.01
19.13
Current year 8.7
Extreme 8.7
19.13
1 year 8.7
Extreme 8.7
19.13
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
03/07Tax

Chief Financial Officer

-5,226 0.0067%
01/07Free

Executive/Senior Manager

11,180 0.0144%
01/07Tax

Controller/Auditor

-937 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+2.66%+9.36%+61.16%-56.04% 1.43B
+0.78%-6.60%-32.39%-16.92% 155B
+2.00%-1.49%-9.45%-6.83% 102B
-0.40%-2.64%+2.29%+56.86% 58.81B
-0.94%-1.23%+39.41%+54.08% 52.82B
+3.22%+2.98%-13.04%-39.58% 41.51B
+1.42%-2.87% - - 32.69B
-0.70%-0.14%-12.76%-46.19% 28.6B
+0.31%+1.35%+62.16%-6.56% 25.27B
+1.87%+1.42%-7.16%-6.96% 20.34B
Average +1.08%-2.38%+10.02%-7.57% 51.79B
Weighted average by Cap. +0.90%-4.29%-6.50%-0.96%

Financials

2026 *2027 *
Net sales 1.68B 1.47B 1.35B 1.24B 2.35B 161B 2.39B 16.14B 6.33B 78.83B 6.29B 6.16B 272B 1.73B 1.51B 1.4B 1.28B 2.43B 166B 2.47B 16.66B 6.54B 81.37B 6.5B 6.35B 280B
Net income 42.73M 37.36M 34.46M 31.68M 60.03M 4.11B 61.06M 411M 161M 2.01B 160M 157M 6.93B 74.56M 65.19M 60.14M 55.28M 105M 7.17B 107M 718M 282M 3.51B 280M 274M 12.09B
Net Debt 1.34B 1.17B 1.08B 992M 1.88B 129B 1.91B 12.89B 5.06B 62.94B 5.03B 4.92B 217B 1.18B 1.03B 948M 872M 1.65B 113B 1.68B 11.32B 4.44B 55.3B 4.42B 4.32B 191B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
16/07/26 USD 18.91 +2.77% 296,295
14/07/26 USD 18.40 -0.97% 1,070,166
13/07/26 USD 18.58 -1.12% 803,323
10/07/26 USD 18.79 +2.18% 951,869
09/07/26 USD 18.39 +6.30% 939,773
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
18.40USD
Average target price
18.00USD
Spread / Average Target
-2.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock